More than 3.1 billion doses have been ordered worldwide of the Oxford-AstraZeneca vaccine, providing a ray of hope in the fight against the pandemic.
EU Buys More Pfizer Vaccine, Parts Of Beijing Locked Down For 1st Time Since July and US COVID-19 Vaccinations Lag
These tickers changing hands for less than $5 per share either draw investors in with their high return potential or send them running.
Big Tech has been in the news and on our minds as this crazy year 2020 winds toward an end.
Semiconductors are one of the modern world’s essential industries, making possible so much of what we rely on or take for granted.
Trump Signs COVID-19 Relief Bill With $600 Checks, Asks Congress To Approve Increase Later President Trump on Sunday signed a $900 billion pandemic relief package which...
Swiss Watch Exports Are Down 24% In 2020 Submitted by Nicholas Colas of DataTrek Research Three topics to discuss today: 1: US stock investors expect to...
US Requires All UK Travelers To Test Negative For COVID, CDC Rules
The UK’s COVID-19 immunization program could get a speed boost, with the country’s drugs regulator expected to make a ruling on AstraZeneca
Last week, Moderna's (MRNA) Covid-19 vaccine candidate mRNA-1273 became the second approved vaccine in the U.S. after it received emergency-use authorization from the FDA. And on...
Pfizer and German partner BioNTech have won a second order with the US government for the supply of an additional 100 million doses of their COVID-19...
With the UK government creating hostilities with the EU, its hopes of switching to other food sources would take years to settle.
Markets ended 2020 in a buoyant mood, with emerging market spreads tightening in the final quarter as the US election result and positive vaccine news provided...
This Week in Apps, the weekly TechCrunch series that recaps the latest in mobile OS news, mobile applications and the overall app economy.
Using miles for travel has been all but impossible for most of 2020. But vaccines will gradually open up options and opportunities for savvy travellers and...
Alaska Air's Cash Burn Rises As Travel Demand Stalls
Eli Lilly & Co. has inked an agreement to snap up Prevail Therapeutics for a total consideration of up to $1.04 billion, as the US drugmaker...
FDA Briefing Doc Confirms Moderna Vaccine Effective, Meets Expectations For Emergency Use Tyler Durden Tue, 12/15/2020 - 08:03 The COVID vaccine made by Moderna is highly...
Eli Lilly & Co. (LLY) announced a 14.9% hike in its quarterly dividend to $0.85 per share from $0.74. The pharmaceutical company said that the new...
Novartis/Incyte’s Jakafi (ruxolitinib) looks unlikely to be added to the list of therapies that can be used against The post Novartis/Incyte draw blank with Jakafi in...
It's that time of year when Wall Street analysts started trotting out the predictions for earnings growth and stock market targets for the coming year. Unfortunately,...
The United States authorized the use of Pfizer Inc’s Covid-19 vaccine on Dec. 11, with the first inoculations expected within days, marking a turning point in...
Sanofi and GlaxoSmithKline have said their COVID-19 vaccine has hit a snag in clinical development, prompting analysts to The post Sanofi/GSK trial woes delay a billion...
Moderna Inc. dosed the first participants in a mid-to-late stage study testing the company's Covid-19 vaccine candidate in adolescents aged 12 to less than 18, and...
British drugmaker AstraZeneca is already running behind early competitors in the hunt for a Covid-19 vaccine with interim data that have received less-than-stellar feedback. With those...
As Covid-19 vaccines start to rollout in the West, the prospect of economic recovery strengthens. Many risks continue to lurk, of course, but for the first...
Cisco Systems has reached an agreement to snap up IMImobile for an aggregate $730 million, including debt, as the network equipment maker seeks to capitalize on...
Is the long-awaited turnaround finally in the cards for Blackberry (BB)? The stock has been on a multiyear downtrend, unable to halt the slide since its...
Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its The post Pfizer cut vaccine production targets because...
As the pandemic drags on there are increasing concerns about “Long COVID” – where symptoms persist long after The post PureTech begins trial of potential ‘Long...